Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Escitalopram Versus SNRI Antidepressants in the Acute Treatment of Major Depressive Disorder: Integrative Analysis of Four Double-Blind, Randomized Clinical Trials

(2015) Susan G. Kornstein et al.   CNS SPECTRUMS

When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed

(2013) L. Citrome et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Placing transdermal selegiline for major depressive disorder into clinical context: Number needed to treat, number needed to harm, and likelihood to be helped or harmed

(2013) Leslie Citrome et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder

(2013) Stuart A. Montgomery et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder

(2013) Gregory M. Asnis et al.   JOURNAL OF CLINICAL PSYCHIATRY

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

(2013) A.L. Auclair et al.   NEUROPHARMACOLOGY

Enantioselective synthesis of levomilnacipran

(2012) Julien Alliot et al.   CHEMICAL COMMUNICATIONS

Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

(2012) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Solving the Antidepressant Efficacy Question: Effect Sizes in Major Depressive Disorder

(2011) Paul A. Vöhringer et al.   CLINICAL THERAPEUTICS

Is Escitalopram Really Relevantly Superior to Citalopram in Treatment of Major Depressive Disorder? A Meta-analysis of Head-to-head Randomized Trials

(2010) Vladimir Trkulja   CROATIAN MEDICAL JOURNAL

Efficacy of escitalopram compared to citalopram: a meta-analysis

(2010) Stuart Montgomery et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antidepressants and Body Weight

(2010) Alessandro Serretti et al.   JOURNAL OF CLINICAL PSYCHIATRY

Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

(2010) Leslie Citrome   POSTGRADUATE MEDICINE

Treatment-Emergent Sexual Dysfunction Related to Antidepressants

(2009) Alessandro Serretti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Compelling or irrelevant? Using number needed to treat can help decide

(2008) L. Citrome   ACTA PSYCHIATRICA SCANDINAVICA

Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with??Other Antidepressants

(2008) Atsuo Nakagawa et al.   CNS DRUGS

Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks

(2008) Leslie Citrome et al.   Expert Review of Neurotherapeutics